SHENGTAI PHARMACEUTICAL, INC. Proceeds from Advances for Construction
SHENGTAI PHARMACEUTICAL, INC. reported Proceeds from Advances for Construction of $1.33 million for the 9-month period ending 2013-03-31, per its 10-Q filed 2013-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromAdvancesForConstruction · last filed 2013-05-15
- SHENGTAI PHARMACEUTICAL, INC. proceeds from advances for construction for the quarter ending 2013-03-31 was -$864.05K.
- SHENGTAI PHARMACEUTICAL, INC. proceeds from advances for construction for the quarter ending 2012-12-31 was $1.49M, a 10.11% increase year-over-year.
- SHENGTAI PHARMACEUTICAL, INC. proceeds from advances for construction for the quarter ending 2012-09-30 was $701.05K.
- SHENGTAI PHARMACEUTICAL, INC. proceeds from advances for construction for the quarter ending 2012-06-30 was -$1.39M.
- SHENGTAI PHARMACEUTICAL, INC. proceeds from advances for construction for fiscal 2012 was -$99.97K.
- SHENGTAI PHARMACEUTICAL, INC. proceeds from advances for construction for fiscal 2011 was -$941.99K.
| Period end | Proceeds from Advances for Construction 3 month | Proceeds from Advances for Construction 6 month | Proceeds from Advances for Construction 9 month | Proceeds from Advances for Construction 12 month |
|---|---|---|---|---|
| 2013-03-31 | -$864.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $629.42K derived: sum of 2 quarters · filed 2013-05-15 | $1.33M 10-Q · filed 2013-05-15 | -$56.23K derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-12-31 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | $2.19M 10-Q · filed 2013-02-14 | $807.82K derived: sum of 3 quarters · filed 2013-02-14 | $751.97K derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-09-30 | $701.05K 10-Q · filed 2012-11-14 | -$685.66K derived: sum of 2 quarters · filed 2012-11-14 | -$741.51K derived: sum of 3 quarters · filed 2013-05-15 | $614.82K derived: sum of 4 quarters · filed 2013-05-15 |
| 2012-06-30 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | -$1.44M derived: sum of 2 quarters · filed 2013-05-15 | -$86.23K derived: sum of 3 quarters · filed 2013-05-15 | -$99.97K 10-K · filed 2012-09-28 |
| 2012-03-31 | -$55.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-15 | $1.30M derived: sum of 2 quarters · filed 2013-05-15 | $1.29M 10-Q · filed 2013-05-15 | $344.75K derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-14 | $1.34M 10-Q · filed 2013-02-14 | $400.60K derived: sum of 3 quarters · filed 2013-02-14 | -$636.50K derived: sum of 4 quarters · filed 2013-02-14 |
| 2011-09-30 | -$13.73K 10-Q · filed 2012-11-14 | -$955.72K derived: sum of 2 quarters · filed 2012-11-14 | -$1.99M derived: sum of 3 quarters · filed 2012-11-14 | |
| 2011-06-30 | -$941.99K derived: 10-K 12 month − 10-Q 9 month · filed 2012-09-28 | -$1.98M derived: sum of 2 quarters · filed 2012-09-28 | -$941.99K 10-K · filed 2012-09-28 | |
| 2011-03-31 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-15 | $0.00 10-Q · filed 2012-05-15 | ||
| 2010-12-31 | $1.04M 10-Q · filed 2012-02-14 |